- Title
- Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
- Creators - without role
- Sung Yong Oh - Dong-A University HospitalWon Seog Kim - Samsung Medical CenterJin Seok Kim - Yonsei UniversitySeok Jin Kim - Samsung Medical CenterDok Hyun Yoon - University of UlsanDeok-Hwan Yang - Chonnam National University Hwasun HospitalWon Sik Lee - Inje University Busan Paik HospitalHyo Jung Kim - Hallym University Sacred Heart HospitalHo-Young Yhim - Chonbuk National University HospitalSeong Hyun Jeong - Ajou UniversityJong Ho Won - Soonchunhyang University HospitalSuee Lee - Dong-A University HospitalJee Hyun Kong - Wonju Severance Christian HospitalSung-Nam Lim - Busan, 48108 Republic of KoreaJun Ho Ji - Sungkyunkwan UniversityKyung A. Kwon - Busan, 46033 Republic of KoreaGyeong-Won Lee - Gyeongsang National University HospitalJae Hoon Lee - Gachon University Gil Medical CenterHo Sup Lee - Kosin University Gospel HospitalHo-Jin Shin - Pusan National University HospitalCheolwon Suh - University of Ulsan
- Publication Details
- Cancer communications (London, England), Vol.39(1), pp.1-10
- Publisher
- BioMed Central
- Grant note
- ;
- Identifiers
- 9944889308331
- Academic Unit
- King Abdullah University of Science & Technology
- Language
- English
- Resource Type
- Journal article
Journal article
Phase II study of R–CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study
Cancer communications (London, England), Vol.39(1), pp.1-10
16/10/2019
PMCID: PMC6796378
PMID: 31619290
Metrics
1 Record Views